Select Publications

Bonner JA et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354(6):567-78. Abstract

D’Souza G et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356(19):1944-56. Abstract

Fakhry C et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100(4):261-9. Abstract

Gillison ML et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92(9):709-20. Abstract

Pfister DG et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm. J Clin Oncol 2006;24(7):1072-8. Abstract

Posner MR et al; TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357(17):1705-15. Abstract

Tishler RB et al. Cetuximab added to docetaxel, cisplatin, 5-fluorouracil induction chemotherapy (C-TPF) in patients with newly diagnosed locally advanced head and neck cancer: A phase I study. Proc ASCO 2008;Abstract 6001.

Wanebo HJ et al. Phase II evaluation of cetuximab (C225) combined with induction paclitaxel and carboplatin followed by C225, paclitaxel, carboplatin, and radiation for stage III/IV operable squamous cancer of the head and neck (ECOG, E2303). Proc ASCO 2007;Abstract 6015.

 

 

 

 

 

 

 

 

 

 

Table of Contents Top of Page

Table of Contents

EDITOR
Neil Love, MD

INTERVIEWS

Corey J Langer, MD
- Select Publications

Robert Haddad, MD
- Select Publications

David I Rosenthal, MD
- Select Publications

Everett E Vokes, MD
- Select Publications

 

CME Information

Faculty Disclosures

Editor's Office